The primary purpose of this protocol is to assess the ExAblate 2100 MR guided high intensity focused ultrasound device as an intervention for treatment of advanced stage pancreatic adenocarcinoma.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Measure acceptable ablation percentage
Timeframe: Immediately after MRgFUS treatment
Total frequency and severity of adverse events
Timeframe: 24 months